Evaluation of Bezlotoxumab in Prevention of Recurrent C. Difficile Infection: A multicenter Single-Arm Study in Office Infusion Centers

/bezlotoxumab-real-world-study-demonstrates-success-in-prevention-of-clostridioides-difficile-infection

Presented on October 3, 2018

Richard L. Hengel, MD
Timothy E. Ritter, MD
Ramesh V. Nathan, MD, FIDSA
Lucinda J. Van Anglen, PharmD
Stephen W. Marcella
Kevin W. Garey, Pharm.D., M.S., FASHP

View Poster

View All